Category: United Kingdom

  • MIL-OSI United Kingdom: City awarded over £1.8m for new PlayZones programme

    Source: City of Leicester

    NINE community multi-sports mini pitches are to be developed in neighbourhoods across Leicester thanks to a £1.8 million funding award.

    The city council has successfully bid for nine grants – totalling £1,858,066 – from the Football Foundation’s national PlayZones Programme.

    PlayZones are safe, inclusive and accessible outdoor facilities that aim to bring communities together through recreational football and other sports.

    The cash will be used to create four new outdoor mini pitches and refurbish five existing ball courts at sites across the city.

    The locations for the four new PlayZones will be Elston Fields, in the Saffron area; Hamilton Park; Mowmacre and Sharmon Crescent Play Park, in Braunstone Frith.

    Existing ball courts will be refurbished at Atlas Close, in Highfields; Armadale Drive, in Netherhall; Cossington recreation Ground, in Belgrave; Eyres Monsell; and Spinney Hill Park.

    All nine of the new PlayZones will be able to be booked for free using The ClubSpark online system, and will have timed floodlighting and secure gates, to help manage access.

    Following installation, the new PlayZones will all offer a programme of structured activities led by professional sports clubs and local community groups.

    Cllr Vi Dempster, assistant city mayor for health and culture, said: “This new funding from the Football Foundation will help us to deliver valuable improvements to nine local communities.

    “Each of the areas have been selected due to a lack of high-quality sports facilities in the community which can create a barrier to physical activity.

    “The new PlayZones will help address that, offering safe and secure ball courts where the community can meet for recreational football and other activities, and enjoy a programme of events and training delivered by local sports clubs and other organisations.”

    All the new PlayZones are being designed following consultation with the local community.

    The Eyres Monsell PlayZone will be the first to be completed and is due to open to the public later this summer.

    Using investment from the Premier League, the FA and the Government through Sport England, the Football Foundation’s PlayZones Programme aims to engage with local communities across the country to create outstanding sports and activity spaces and tackle inequalities in participation.

    MIL OSI United Kingdom

  • MIL-OSI: Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

    Source: GlobeNewswire (MIL-OSI)

    PALM BEACH, Fla., July 08, 2025 (GLOBE NEWSWIRE) — FN Media Group News Commentary – The global oncology market, including breakthrough treatments, is experiencing substantial growth, with revenues projected to reach hundreds of billions of dollars in the coming years. Several factors are driving this expansion, including rising cancer incidence, advancements in therapies like precision medicine and immunotherapy, and increased investment in research and development. A report from Grand View Research said that the global breakthrough therapy designation market size is projected to grow at a CAGR of 14.2% through 2030. It is a process designed to escalate the development and assessment of sanctioning of drugs & biologics that are proposed for treating severe diseases, whereas primary clinical evidence notifies that the drug determines considerable enhancement over existing therapy on a clinically significant endpoint. Furthermore, the BT (Breakthrough) designation lets pharma companies hasten the developmental process by offering additional support and assistance from the FDA and making medications available to the public faster. The report continued: “Apart from breakthrough designation therapy, there are some important tools, all of which have been in place for many years, such as fast-track designation, accelerated approval, and priority review. All of these are inclined toward approving drugs used to treat serious disorders. Although these processes can reduce a drug’s time to market, standard clinical testing is required for the development process, which usually involves three phases of large-scale and controlled trials.” Active oncology biotech and pharma companies in the markets this week include Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC), Mustang Bio, Inc. (NASDAQ: MBIO), Verastem Oncology (NASDAQ: VSTM), Cardiff Oncology, Inc. (NASDAQ: CRDF), AstraZeneca PLC (NASDAQ: AZN).

    Grand View Research continued: “The increasing prevalence of life-threatening conditions and the necessity for the rapid development of pipeline drugs are also some factors that propel the breakthrough therapy drug market. This is primarily driven by the significant unmet need for effective treatments for severe conditions currently available. Manufacturing companies are particularly attentive to drugs designated as breakthrough therapies due to the accelerated market access and higher returns on investment. Breakthrough therapy drugs often undergo less extensive clinical trials, which is a direct consequence of their market designation. The FDA’s enhanced support for small-scale industries in research and development, including increased funding and expedited drug approval processes, is further stimulating the market for breakthrough therapy drugs. Collectively, these elements are pushing the breakthrough therapy drug market forward. Further, innovative gene and cell therapies are offering new treatment decisions for previously untreatable illnesses, mainly drifting to more breakthrough therapy designations. Moreover, the regulatory support agencies are streamlining processes and offering assistance for breakthrough therapies to speed up their development and sanction. Another aspect leading the breakthrough therapy designations is the cross-sector collaborations between academic institutions, pharmaceutical companies, and research institutes that are lifting the upgradation and the advancement of new breakthrough therapies completely.”

    Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC) Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies

    • Comparison with multiple landmark first-line metastatic pancreatic ductal adenocarcinoma studies substantiates strong two-year survival benefit of 21.9% vs. 9.2% historical benchmark
    • Consistent survival benefit compared to standard-of-care chemotherapy in randomized studies in the large HR+/HER2- metastatic breast cancer indication
    • Data from over 1,100 patients across tumor types reveals a favorable, well-understood safety profile

    Oncolytics Biotech ® Inc. ($ONCY $ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced a strategic update highlighting its compelling clinical data from two tumor types and outlining a sharpened focus on advancing pelareorep, the Company’s intravenously delivered oncolytic virus immunotherapy, into registration-enabling studies.

    “We are no longer in the business of funding proof-of-concept studies,” said Jared Kelly, Chief Executive Officer of Oncolytics. “We have meaningful clinical data in hand—not just signals. The survival benefit across multiple tumor types demands a focused approach to take pelareorep directly into registration-enabling trials. We will use our fast-track status to find the most efficient regulatory path forward this summer to advance our platform in a product technology.”

    Results from two completed first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) trials demonstrate a strong and consistent efficacy signal showing extremely rare 2-year overall survival rates of 21.9% vs. 9.2% based on pooled data from over 100 patients across two studies evaluating pelareorep combined with a chemotherapy backbone. In addition, a best-in-class 62% objective response rate (ORR) was observed in a single-arm study of pelareorep in combination with a chemotherapy backbone and a checkpoint inhibitor in 13 evaluable patients. These results collectively represent promising efficacy for a therapeutic regimen that includes an immunotherapy in this difficult-to-treat cancer. Currently, there are no approved immunotherapies for first-line treatment of mPDAC…

    …Pelareorep’s clinical activity in HR+/HER2- metastatic breast cancer – a large indication with continued significant unmet medical need and no currently approved immunotherapies – has been demonstrated in two randomized phase 2 studies, both of which showed a median overall survival (mOS) benefit of greater than 10 months compared to standard-of-care chemotherapy (IND.213 mOS: 21.0 vs. 10.8 months; BRACELET-1 mOS: not statistically reached; conservative estimate = 32.1 months vs. 18.2 months). In the randomized, controlled BRACELET-1 study, pelareorep combined with paclitaxel yielded a 12.1-month median progression-free survival (PFS) compared to 6.4 months in the paclitaxel alone control arm.

    “Pelareorep represents a tipping point for immunotherapy in cold tumors,” said Dr. Thomas Heineman, Chief Medical Officer of Oncolytics. “It is delivering consistent immunologic and clinical responses in multiple tumor types. Most impressively, pelareorep activates the immune system to produce clinical benefits in cancers that are typically unresponsive to immunotherapies like mPDAC and unresectable HR+/HER2- breast cancer, creating new oncology entry points for immune-based combination therapies.” CONTINUED Read these full press releases and more news for ONCY at: https://www.financialnewsmedia.com/news-oncy/

    Other recent oncology developments in the biotech industry of note include:

    Mustang Bio, Inc. (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, recently announced that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation to Mustang for MB-101 (IL13Ra2-targeted CAR T-cells) for the treatment of recurrent diffuse and anaplastic astrocytoma (astrocytomas) and glioblastoma (GBM).

    The FDA grants Orphan Drug Designation to drugs and biologics that are intended for safe and effective treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the U.S. Orphan Drug Designation provides certain incentives, such as tax credits toward the cost of clinical trials upon approval and prescription drug user fee waivers. If a product receives Orphan Drug Status from the FDA, that product is entitled to seven years of market exclusivity for the disease in which it has Orphan Drug designation, which is independent from intellectual property protection.

    Verastem Oncology (NASDAQ: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, recently announced that updated results from the Phase 1/2 FRAME study conducted by The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust were published online in Nature Medicine. The full manuscript, titled “Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial,” was the first-in-human study to evaluate the safety, tolerability, and efficacy of avutometinib in combination with defactinib in patients with low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), and other solid tumor types.

    “The FRAME study was the early foundation for the recent FDA approval of avutometinib plus defactinib in KRAS-mutated recurrent low-grade serous ovarian cancer and we are pleased to see that the mature data set continues to show the safety and tolerability of this combination therapy,” said Dan Paterson, president and chief executive officer of Verastem Oncology. “This supports our ongoing commitment to advancing our research into the combination for use in other solid tumors, including RAMP 205 in first-line metastatic pancreatic cancer.”

    Cardiff Oncology, Inc. (NASDAQ: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, recently announced the company has appointed Roger Sidhu, MD, as Chief Medical Officer. Dr. Sidhu is a veteran executive and clinician with over 20 years of experience and a strong track record of success in oncology research, development, and regulatory strategy. Dr. Sidhu succeeds Dr. Fairooz Kabbinavar who will remain with the company in an advisory role. The company also announced it will share additional clinical data from its lead program in RAS-mutated mCRC on July 29, 2025.

    “We are pleased to welcome Dr. Sidhu to lead the clinical program for onvansertib through the next phase of development. Dr. Sidhu is a respected clinician and seasoned executive with a proven track record of advancing innovative therapies through late-stage clinical development across multiple therapeutic areas including in first-line mCRC. As we move forward, we thank Dr. Kabbinavar for his leadership in progressing onvansertib’s clinical development across multiple tumor types,” said Mark Erlander, Chief Executive Officer of Cardiff Oncology. “In addition to today’s medical leadership transition, we are announcing our plan to share an update of clinical data from the ongoing CRDF-004 trial on July 29, at which point we expect to release a substantive dataset.”

    AstraZeneca PLC (NASDAQ: AZN)‘s Imfinzi (durvalumab) has been approved in the European Union (EU) for the treatment of adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as monotherapy adjuvant treatment after radical cystectomy (surgery to remove the bladder).

    The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use and is based on results from the NIAGARA Phase III trial, which were published in The New England Journal of Medicine.

    In a planned interim analysis, the Imfinzi-based perioperative regimen demonstrated a statistically significant 32% reduction in the risk of disease progression, recurrence, not undergoing surgery, or death versus neoadjuvant chemotherapy with radical cystectomy alone (based on event-free survival [EFS] hazard ratio [HR] of 0.68; 95% confidence interval [CI] 0.56-0.82; p<0.0001). Estimated median EFS was not yet reached for the Imfinzi arm versus 46.1 months for the comparator arm. An estimated 67.8% of patients treated with the regimen were event free at two years compared to 59.8% in the comparator arm.

    About FN Media Group:

    At FN Media Group, via our top-rated online news portal at www.financialnewsmedia.com, we are one of the very few select firms providing top tier one syndicated news distribution, targeted ticker tag press releases and stock market news coverage for today’s emerging companies. #pressreleases #tickertagpressreleases

    Follow us on Facebook to receive emerging news updates: https://www.facebook.com/financialnewsmedia

    Follow us on Twitter for real time Breaking News: https://twitter.com/FNMgroup

    Follow us on Linkedin: https://www.linkedin.com/in/financialnewsmedia/

    DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM was compensated forty nine hundred dollars for news coverage of the current press releases issued by Oncolytics Biotech® Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

    This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

    Contact Information:

    Media Contact email: editor@financialnewsmedia.com – +1(561)325-8757 

    SOURCE: FN Media Group

    The MIL Network

  • MIL-OSI: Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

    Source: GlobeNewswire (MIL-OSI)

    PALM BEACH, Fla., July 08, 2025 (GLOBE NEWSWIRE) — FN Media Group News Commentary – The global oncology market, including breakthrough treatments, is experiencing substantial growth, with revenues projected to reach hundreds of billions of dollars in the coming years. Several factors are driving this expansion, including rising cancer incidence, advancements in therapies like precision medicine and immunotherapy, and increased investment in research and development. A report from Grand View Research said that the global breakthrough therapy designation market size is projected to grow at a CAGR of 14.2% through 2030. It is a process designed to escalate the development and assessment of sanctioning of drugs & biologics that are proposed for treating severe diseases, whereas primary clinical evidence notifies that the drug determines considerable enhancement over existing therapy on a clinically significant endpoint. Furthermore, the BT (Breakthrough) designation lets pharma companies hasten the developmental process by offering additional support and assistance from the FDA and making medications available to the public faster. The report continued: “Apart from breakthrough designation therapy, there are some important tools, all of which have been in place for many years, such as fast-track designation, accelerated approval, and priority review. All of these are inclined toward approving drugs used to treat serious disorders. Although these processes can reduce a drug’s time to market, standard clinical testing is required for the development process, which usually involves three phases of large-scale and controlled trials.” Active oncology biotech and pharma companies in the markets this week include Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC), Mustang Bio, Inc. (NASDAQ: MBIO), Verastem Oncology (NASDAQ: VSTM), Cardiff Oncology, Inc. (NASDAQ: CRDF), AstraZeneca PLC (NASDAQ: AZN).

    Grand View Research continued: “The increasing prevalence of life-threatening conditions and the necessity for the rapid development of pipeline drugs are also some factors that propel the breakthrough therapy drug market. This is primarily driven by the significant unmet need for effective treatments for severe conditions currently available. Manufacturing companies are particularly attentive to drugs designated as breakthrough therapies due to the accelerated market access and higher returns on investment. Breakthrough therapy drugs often undergo less extensive clinical trials, which is a direct consequence of their market designation. The FDA’s enhanced support for small-scale industries in research and development, including increased funding and expedited drug approval processes, is further stimulating the market for breakthrough therapy drugs. Collectively, these elements are pushing the breakthrough therapy drug market forward. Further, innovative gene and cell therapies are offering new treatment decisions for previously untreatable illnesses, mainly drifting to more breakthrough therapy designations. Moreover, the regulatory support agencies are streamlining processes and offering assistance for breakthrough therapies to speed up their development and sanction. Another aspect leading the breakthrough therapy designations is the cross-sector collaborations between academic institutions, pharmaceutical companies, and research institutes that are lifting the upgradation and the advancement of new breakthrough therapies completely.”

    Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC) Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies

    • Comparison with multiple landmark first-line metastatic pancreatic ductal adenocarcinoma studies substantiates strong two-year survival benefit of 21.9% vs. 9.2% historical benchmark
    • Consistent survival benefit compared to standard-of-care chemotherapy in randomized studies in the large HR+/HER2- metastatic breast cancer indication
    • Data from over 1,100 patients across tumor types reveals a favorable, well-understood safety profile

    Oncolytics Biotech ® Inc. ($ONCY $ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced a strategic update highlighting its compelling clinical data from two tumor types and outlining a sharpened focus on advancing pelareorep, the Company’s intravenously delivered oncolytic virus immunotherapy, into registration-enabling studies.

    “We are no longer in the business of funding proof-of-concept studies,” said Jared Kelly, Chief Executive Officer of Oncolytics. “We have meaningful clinical data in hand—not just signals. The survival benefit across multiple tumor types demands a focused approach to take pelareorep directly into registration-enabling trials. We will use our fast-track status to find the most efficient regulatory path forward this summer to advance our platform in a product technology.”

    Results from two completed first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) trials demonstrate a strong and consistent efficacy signal showing extremely rare 2-year overall survival rates of 21.9% vs. 9.2% based on pooled data from over 100 patients across two studies evaluating pelareorep combined with a chemotherapy backbone. In addition, a best-in-class 62% objective response rate (ORR) was observed in a single-arm study of pelareorep in combination with a chemotherapy backbone and a checkpoint inhibitor in 13 evaluable patients. These results collectively represent promising efficacy for a therapeutic regimen that includes an immunotherapy in this difficult-to-treat cancer. Currently, there are no approved immunotherapies for first-line treatment of mPDAC…

    …Pelareorep’s clinical activity in HR+/HER2- metastatic breast cancer – a large indication with continued significant unmet medical need and no currently approved immunotherapies – has been demonstrated in two randomized phase 2 studies, both of which showed a median overall survival (mOS) benefit of greater than 10 months compared to standard-of-care chemotherapy (IND.213 mOS: 21.0 vs. 10.8 months; BRACELET-1 mOS: not statistically reached; conservative estimate = 32.1 months vs. 18.2 months). In the randomized, controlled BRACELET-1 study, pelareorep combined with paclitaxel yielded a 12.1-month median progression-free survival (PFS) compared to 6.4 months in the paclitaxel alone control arm.

    “Pelareorep represents a tipping point for immunotherapy in cold tumors,” said Dr. Thomas Heineman, Chief Medical Officer of Oncolytics. “It is delivering consistent immunologic and clinical responses in multiple tumor types. Most impressively, pelareorep activates the immune system to produce clinical benefits in cancers that are typically unresponsive to immunotherapies like mPDAC and unresectable HR+/HER2- breast cancer, creating new oncology entry points for immune-based combination therapies.” CONTINUED Read these full press releases and more news for ONCY at: https://www.financialnewsmedia.com/news-oncy/

    Other recent oncology developments in the biotech industry of note include:

    Mustang Bio, Inc. (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, recently announced that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation to Mustang for MB-101 (IL13Ra2-targeted CAR T-cells) for the treatment of recurrent diffuse and anaplastic astrocytoma (astrocytomas) and glioblastoma (GBM).

    The FDA grants Orphan Drug Designation to drugs and biologics that are intended for safe and effective treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the U.S. Orphan Drug Designation provides certain incentives, such as tax credits toward the cost of clinical trials upon approval and prescription drug user fee waivers. If a product receives Orphan Drug Status from the FDA, that product is entitled to seven years of market exclusivity for the disease in which it has Orphan Drug designation, which is independent from intellectual property protection.

    Verastem Oncology (NASDAQ: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, recently announced that updated results from the Phase 1/2 FRAME study conducted by The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust were published online in Nature Medicine. The full manuscript, titled “Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial,” was the first-in-human study to evaluate the safety, tolerability, and efficacy of avutometinib in combination with defactinib in patients with low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), and other solid tumor types.

    “The FRAME study was the early foundation for the recent FDA approval of avutometinib plus defactinib in KRAS-mutated recurrent low-grade serous ovarian cancer and we are pleased to see that the mature data set continues to show the safety and tolerability of this combination therapy,” said Dan Paterson, president and chief executive officer of Verastem Oncology. “This supports our ongoing commitment to advancing our research into the combination for use in other solid tumors, including RAMP 205 in first-line metastatic pancreatic cancer.”

    Cardiff Oncology, Inc. (NASDAQ: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, recently announced the company has appointed Roger Sidhu, MD, as Chief Medical Officer. Dr. Sidhu is a veteran executive and clinician with over 20 years of experience and a strong track record of success in oncology research, development, and regulatory strategy. Dr. Sidhu succeeds Dr. Fairooz Kabbinavar who will remain with the company in an advisory role. The company also announced it will share additional clinical data from its lead program in RAS-mutated mCRC on July 29, 2025.

    “We are pleased to welcome Dr. Sidhu to lead the clinical program for onvansertib through the next phase of development. Dr. Sidhu is a respected clinician and seasoned executive with a proven track record of advancing innovative therapies through late-stage clinical development across multiple therapeutic areas including in first-line mCRC. As we move forward, we thank Dr. Kabbinavar for his leadership in progressing onvansertib’s clinical development across multiple tumor types,” said Mark Erlander, Chief Executive Officer of Cardiff Oncology. “In addition to today’s medical leadership transition, we are announcing our plan to share an update of clinical data from the ongoing CRDF-004 trial on July 29, at which point we expect to release a substantive dataset.”

    AstraZeneca PLC (NASDAQ: AZN)‘s Imfinzi (durvalumab) has been approved in the European Union (EU) for the treatment of adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as monotherapy adjuvant treatment after radical cystectomy (surgery to remove the bladder).

    The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use and is based on results from the NIAGARA Phase III trial, which were published in The New England Journal of Medicine.

    In a planned interim analysis, the Imfinzi-based perioperative regimen demonstrated a statistically significant 32% reduction in the risk of disease progression, recurrence, not undergoing surgery, or death versus neoadjuvant chemotherapy with radical cystectomy alone (based on event-free survival [EFS] hazard ratio [HR] of 0.68; 95% confidence interval [CI] 0.56-0.82; p<0.0001). Estimated median EFS was not yet reached for the Imfinzi arm versus 46.1 months for the comparator arm. An estimated 67.8% of patients treated with the regimen were event free at two years compared to 59.8% in the comparator arm.

    About FN Media Group:

    At FN Media Group, via our top-rated online news portal at www.financialnewsmedia.com, we are one of the very few select firms providing top tier one syndicated news distribution, targeted ticker tag press releases and stock market news coverage for today’s emerging companies. #pressreleases #tickertagpressreleases

    Follow us on Facebook to receive emerging news updates: https://www.facebook.com/financialnewsmedia

    Follow us on Twitter for real time Breaking News: https://twitter.com/FNMgroup

    Follow us on Linkedin: https://www.linkedin.com/in/financialnewsmedia/

    DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM was compensated forty nine hundred dollars for news coverage of the current press releases issued by Oncolytics Biotech® Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

    This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

    Contact Information:

    Media Contact email: editor@financialnewsmedia.com – +1(561)325-8757 

    SOURCE: FN Media Group

    The MIL Network

  • MIL-OSI United Kingdom: MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms (hot flushes) caused by menopause  

    Source: United Kingdom – Executive Government & Departments

    Press release

    MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms (hot flushes) caused by menopause  

    The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 8 July, become the first regulator in the world to approve elinzanetant (Lynkuet) for the treatment of moderate to severe vasomotor symptoms (hot flushes) associated with the menopause.

    The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 8 July, become the first regulator in the world to approve elinzanetant (Lynkuet) for the treatment of moderate to severe vasomotor symptoms (hot flushes) associated with the menopause. 

    When oestrogen levels drop during menopause, certain brain cells become overactive and interrupt the body’s ability to control temperature, which leads to hot flushes and night sweats.   Elinzanetant is a new non-hormonal medication which works by calming these signals in the brain, helping bring the body’s temperature control back into balance. 

    It may also help improve sleep problems that often come with menopause.   This medicine is administered in tablet form, to be taken orally. 

    Julian Beach, MHRA Interim Executive Director of Healthcare Quality and Access, said:  

    “Hot flushes and night sweats associated with menopause can have a significant negative impact on quality of life.  

    “We are therefore pleased to announce our approval of elinzanetant, which has met the MHRA’s standards for safety, quality and effectiveness. 

     “Elinzanetant offers a non-hormonal alternative for those who may not be able to, or prefer not to, take hormone-based therapies. As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used.” 

    Elinzanetant’s approval is based on results from the OASIS clinical trials, which involved over 1,400 women aged 40 to 65 across several countries. These studies showed that taking a daily 120 mg tablet of elinzanetant significantly reduced the number and intensity of hot flushes and night sweats over 26 to 52 weeks, compared to a placebo.  

    Like all medicines, this medicine can cause side effects in some people. A full list of side effects can be found in the Patient Information Leaflet (PIL) or the Summary of Product Characteristics (SmPC), available on the MHRA website within 7 days of approval.    

    Anyone who suspects they are having a side effect from this medicine should talk to their doctor, pharmacist or nurse and report it directly to the MHRA Yellow Card scheme, either through the website (https://yellowcard.mhra.gov.uk/) or by searching the Google Play or Apple App stores for MHRA Yellow Card.     

    Notes to editors     

    • The new marketing authorisation was granted on 8 July 2025 to Bayer plc. 

    • This national approval was granted after an Access Consortium new active substance work-sharing initiative (NASWSI) procedure. 

    • More information can be found in the Summary of Product Characteristics and Patient Information leaflets which will be published on the MHRA Products website within 7 days of approval.   

    • The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe.  All our work is underpinned by robust and fact-based judgements to ensure that the benefits justify any risks.   

    • The MHRA is an executive agency of the Department of Health and Social Care.   

    • For media enquiries, please contact the newscentre@mhra.gov.uk, or call on 020 3080 7651.

    Updates to this page

    Published 8 July 2025

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Statement to the 109th Session of the Executive Council of the OPCW

    Source: United Kingdom – Executive Government & Departments

    Speech

    Statement to the 109th Session of the Executive Council of the OPCW

    Statement by Director of Defence and International Security, Foreign Commonwealth and Development Office, Mr Stephen Lillie, at the 109th Executive Council of the Organisation for the Prohibition of Chemical Weapons.

    Mr Chair, Director General, Excellencies, Distinguished Delegates,

    The UK welcomes Your Excellency, Ambassador Thomas Schieb as the new Chair of the Executive Council at this critical time. You have our full support.

    Our thanks also to the Director General Fernando Arias for his detailed report.

    Mr Chair,

    Syria has demonstrated its commitment to destroying remaining elements of the Assad regime’s chemical weapons programme; and to holding accountable those responsible. The commitment of the new Syrian Government to achieve this, and it’s support to the Technical Secretariat has been exemplary.

    The UK welcomes the efforts of OPCW staff on the ground and the important progress made during the three recent deployments they have undertaken this year. At last, this Council can look forward to Syria completing the task mandated by the UN Security Council after the horrific sarin attack in 2013, namely the complete destruction of the Assad regime’s chemical weapons programme.

    We must take this opportunity and move at pace to deliver this work in the face of complex practical challenges. Close coordination will be needed between the Technical Secretariat, Syria and supporting States Parties to outline a sensible path and address immediate risks, while ensuring robust OPCW verification.

    Both Syria and the OPCW will each need significant financial and in-kind support to finish the job. On 5 July, whilst in Damascus, my Foreign Secretary announced an additional £2 million of UK support to the OPCW’s Syria missions. This comes in addition to the £837,000 already transferred since December. We urge other states to provide complementary technical, financial and logistical assistance as soon as possible. Concerted international coordination of both financial and in-kind support is essential – we urge the TS and Syria to establish the mechanisms to do this without delay.

    Mr Chair,

    While we take the opportunity to turn the page on a dark period of the widespread use of chemical weapons in Syria this century, we must also redouble our efforts to make sure that all parties to the Chemical Weapons Convention ensure that they do all within their power to uphold the Convention, and to ensure that its central norm against use is re-enforced.

    Today marks the seventh anniversary of the tragic death of Dawn Sturgess. She was killed as a result of Russia’s callous use of the nerve agent novichok in Salisbury.

    While Syria seeks to rid itself of the previous regime’s chemical weapons, Russia continues to use chemical weapons and riot control agents on the battlefield in Ukraine. The statement published last week by the Dutch and German intelligence services in which they warn of the intensifying use of chemicals by Russia on the battlefield is a cause for great concern. This blatant disregard for the Convention is outrageous.

    The British government announced today a second set of sanctions in response to Russia’s use of chemical weapons in Ukraine. The measures designate senior members of Russia’s Radiological, Chemical and Biological Defence Troops; and a Russian entity responsible for supplying RG-Vo riot control agent grenades to the Russian military being used against Ukraine.

    The UK has provided a further £400,000 in extra-budgetary funding to the OPCW Assistance to Ukraine Fund. Since 2022, the UK has contributed over one million euros to this fund. Our support for Ukraine is steadfast. To quote Foreign Secretary David Lammy – “today – and every day – we stand with Ukraine”.

    Mr Chair,

    We are deeply concerned by the US determination that chemical weapons have been used in Sudan. We have noted Sudan’s response to Article IX requests submitted by the delegations of Chad, Mauritania, Benin and Guinea Bissau.  We call on Sudan to follow through on its stated commitment to investigate thoroughly.

    Mr Chair,

    You will manage the process by which we will select the next Director General. DG Arias’ successor will have big shoes to fill. They will need to continue his work to shape the Organisation so it is fit to meet the challenges and opportunities of the 21st century:  including consigning chemical weapons to history, ensuring that there is no re-emergence of a chemical threat and advancing work on emerging technologies. Promoting and ensuring a diverse TS staff, with gender equality at its heart, and strengthening capacity building around the world will be essential priorities.

    Updates to this page

    Published 8 July 2025

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Major boost for Sizewell C nuclear plan as French energy giant EDF confirms investment

    Source: United Kingdom – Executive Government & Departments

    Press release

    Major boost for Sizewell C nuclear plan as French energy giant EDF confirms investment

    Thousands of UK jobs will be created as French energy firm EDF confirms today it will take a 12.5% stake in Sizewell C – in a major boost for UK growth and energy security.

    • French company EDF confirms it will take a 12.5% stake in Sizewell C nuclear plant, supporting thousands of UK jobs and boosting UK’s energy security.
    • Follows £14.5 billion funding confirmed by UK government last month and takes Britain closer to ‘golden age’ of nuclear power.
    • Prime Minister Keir Starmer to welcome French President Emmanuel Macron to Downing Steet tomorrow to make progress on shared priorities and deliver for British people.

    Thousands of UK jobs will be created as French energy firm EDF confirms today it will take a 12.5% stake in Sizewell C – in a major boost for UK growth and energy security.  

    EDF is the first shareholder to announce its backing for the nuclear plant alongside the UK government, who confirmed £14.2 billion of funding into the project in last month’s Spending Review.  

    Today’s announcement takes Sizewell C one step closer to being given the green light, when it will help to deliver the UK’s ‘golden age’ of nuclear and see clean power supplied to millions of homes. 

    Further investors and details on the project’s financing will be confirmed at the point of the Final Investment Decision, targeted for this summer. 

    Nuclear energy is crucial to a mixed power supply – providing a backbone of low-carbon power alongside renewables, which is the only way to bring down bills for good by ending the UK’s dependence on fossil fuel markets.

    At peak construction, Sizewell C will support 10,000 jobs, and thousands more in the nationwide supply chain, and create 1,500 apprenticeships. 

    It comes as Prime Minister Keir Starmer welcomes French President Emmanuel Macron to the UK ahead of the UK-France Summit on Thursday, which will drive forward co-operation with one of our closest neighbours on shared priorities – energy, growth, defence and security, and migration.  

    Since taking office last year, the Prime Minister has been determined to bolster the UK’s position on the world stage and improve our relationship with our closest partners in order to deliver for the British people.  

    Today’s announcement marks another vote of confidence in that approach, cementing the UK as an increasingly attractive investment destination and a reliable partner.  

    Previous governments had shied away from making real progress on Sizewell C – leaving the UK exposed when Putin’s illegal invasion into Ukraine created major shocks in the international oil and gas market.

    Prime Minister Keir Starmer said: 

    I’ve been clear there will be no more dithering and delay on Sizewell C – and this investment takes us a step closer to the benefits it will bring to the British people. 

    Lower energy bills, thousands more jobs and apprenticeships, and better energy security – this is not only a vote of confidence in the UK as an investment destination, it is our Plan for Change in action.

    Chancellor of the Exchequer Rachel Reeves said:

    This investment goes hand in hand with the £14.2 billion set aside at last month’s Spending Review to deliver the biggest nuclear building programme in a generation.

    It is part of the new confidence we’re seeing in the UK as an investment destination and will create thousands of high-skilled, high-paid jobs to help deliver on our Plan for Change.

    Energy Secretary Ed Miliband said:  

    Thousands of jobs and clean power for millions of homes are one step closer today as we welcome this investment into Sizewell C – delivering a golden age of new nuclear to protect family finances and boost energy security. 

    This agreement is a landmark moment in the UK and France’s long-standing partnership in civil nuclear, and a testament to our countries’ strong relationship.

    In addition, Bpifrance, France’s export credit agency, is set to provide a £5 billion debt guarantee to the power station.  

    This supports lending to the project from a number of leading commercial banks and is enabled by Sizewell C’s innovative funding model that spreads costs between consumers, taxpayers and private investors.  

    The UK Government will remain a significant shareholder in the project – ensuring we have oversight of the progress and limiting delays.  

    The government’s nuclear programme is now the most ambitious for a generation – once small modular reactors and Sizewell C come online in the 2030s, combined with Hinkley Point C, this will deliver more new nuclear power to the grid than over the previous half century combined. 

    In another important step forward for UK–France energy collaboration, UK company Urenco have signed a 15-year deal with EDF to produce fuel for nuclear power stations, helping to deliver clean power and enhanced energy security in Europe.

    This multi-billion euro contract, with significant value for the UK, will support Urenco UK’s workforce of more than 1,400 people and support the company’s important contribution to UK economic growth, which represented more than £256 million in 2023. 

    French engineering company Assystem has also announced plans to double its nuclear workforce in the UK, creating 1,000 new engineering, digital and management jobs by 2030 across 10 UK sites, including in Sunderland, Blackburn, Derby, Bristol and London.

    Updates to this page

    Published 8 July 2025

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: City of York Council investing £500,000 in green spaces

    Source: City of York

    Clarence Gardens

    Published Monday, 7 July 2025

    City of York Council has announced a significant £500,000 capital investment over the next two years to revitalise parks, play areas, and public green spaces across the city.

    The Executive is set to approve the proposed criteria and prioritisation framework that will guide the funding allocation and ensure the greatest community impact.

    This initiative marks the first major investment in York’s public spaces in several years and comes in response to widespread resident support and strategic ambitions laid out in the Council Plan 2023 to 2027. A key focus is ensuring accessible and sustainable outdoor environments that enhance biodiversity, wellbeing, and social inclusion. Work on assessing the conservation needs of our much-valued War Memorials will take place alongside the parks projects.

    Strategic Benefits

    The funding aligns with national findings from the “Space to Thrive” report by The National Lottery, which highlights the vital role parks play in supporting physical and mental health, community engagement, and local economies. The council aims to amplify these benefits by engaging residents, community organisations, and volunteer groups in improving green spaces citywide.

    The decision also aligns with the council’s core commitments to equality and health. By prioritising sites in high deprivation areas and those with ageing infrastructure, the programme seeks to redress inequalities in access to quality recreational space.

    Next Steps

    Council officers will assess potential projects over the summer, with a final decision on funded schemes to be presented to the Executive this September. Recruitment for a dedicated project officer is already underway to support delivery through March 2027.

    Cllr Jenny Kent, Executive Member for Environment and Climate Emergency, said: “In investing in our parks and public spaces, we’re not just enhancing infrastructure or play equipment – we’re investing in communities, public health, and a greener future. York people love our parks and have spoken clearly about the value of these shared spaces. This project reflects our commitment to creating a more vibrant, inclusive, and sustainable city, with people and pride in place at its heart.”

    For more information, visit the council’s website or read the Space to Thrive report at Space to Thrive – National Lottery Heritage Fund.

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Major progress at York Central as new travel routes open to the public

    Source: United Kingdom – Government Statements

    Press release

    Major progress at York Central as new travel routes open to the public

    Residents and visitors can now enjoy safer, greener and more attractive journeys into York city centre as new travel routes through the York Central development open.

    Replacing Leeman Road as a through-route, the new road runs from Salisbury Road to Marble Arch, with dedicated wider pedestrian and cycle paths alongside it.

    Designed with sustainability and comfort in mind, the new infrastructure features Hudson Boulevard, a standout walking and cycling route complete with high-quality materials, seating, and a striking central rain garden.

    The opening of new travel routes through York Central is evidence of how Homes England is working with local leaders to transform underused, brownfield land into thriving communities and creating places people can be proud of.

    Leon Guyett, Project Director on behalf of Homes England and Network Rail, said:

    The opening of the new road, walking and cycling routes is a huge step forward for the project, providing safer and more attractive journeys into the city centre for pedestrians, cyclists, bus users and drivers.

    This modern infrastructure not only supports sustainable transport but also plays a key role in unlocking the wider York Central development for new homes, public spaces and commercial opportunities.

    The second phase of works will see two new bridges constructed over the East Coast Main Line, completing the direct link to Water End. This will further reduce traffic through areas such as Salisbury Terrace and enhance connections for all road users.

    Funding from Homes England has supported turning local ambitions into reality, creating well-connected neighbourhoods that support both economic growth and environmental goals.

    Cllr Kate Ravilious, Executive Member for Transport at City of York Council, commented:

    This is a significant milestone for York Central. These new routes help unlock a transformative opportunity for the city—thousands of homes, well-paid jobs and welcoming public spaces.

    The improved walking, cycling and bus provision is already making a difference, and Hudson Boulevard in particular is a beautiful and functional new feature. Looking ahead, the new road will ultimately connect directly to Water End, removing through-traffic from nearby residential areas and improving neighbourhood environments.

    Matt Mosley, Regional Director for Sisk Infrastructure, added:

    Sisk is proud to have delivered this transformative infrastructure. We’ve worked closely with Homes England to create lasting value for York, both economically and socially.

    As one of the UK’s largest city centre brownfield regeneration projects, York Central is backed by over £155 million in public funding. Construction on key infrastructure began in 2022 and will ultimately include more than 2km of new roads, bus lanes, pedestrian footpaths and cycleways.

    In 2024, McLaren Property and Arlington Real Estate were appointed as development partners to deliver up to 2,500 homes, 1 million square feet of commercial space, a new western entrance to York Station, and extensive new green spaces. At least 20% of the homes will be affordable, and the project is expected to support over 6,500 jobs.

    The scheme will also enable a major expansion of the National Railway Museum, enhancing York’s position as a cultural and economic hub.

    For the latest updates, visit www.yorkcentral.info or the developer’s website at www.yorkcentral.uk.

    About York Central

    York Central is one of the UK’s largest city centre regeneration sites. The scheme has unprecedented support from Central, Regional and Local government, with £155m already committed to building key up front infrastructure.

    The site is being brought forward by majority landowners and master developers McLaren Property and Arlington Real Estate, Homes England and Network Rail in collaboration with key stakeholders, the City of York Council and the National Railway Museum.

    For more information visit: https://www.yorkcentral.info

    Updates to this page

    Published 8 July 2025

    MIL OSI United Kingdom

  • MIL-OSI: Intermex Launches a new Remittance-as-a-Service (RaaS) Platform to Help Businesses Simplify Cross-Border Payments

    Source: GlobeNewswire (MIL-OSI)

    MIAMI, July 08, 2025 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (“Intermex” or the “Company”), a leading money remittance provider to Latin America and the Caribbean, today announced the launch of its fully redesigned Remittance-as-a-Service (RaaS) platform. The upgraded service gives businesses a straightforward way to embed fast, secure cross-border money transfers into their own customer experiences.

    A growing number of companies – from innovative U.S. fintechs to well-established payment providers – are already harnessing Intermex’s Remittance-as-a-Service platform to unlock new cross-border revenue streams.

    Through Intermex’s RaaS platform, companies can introduce their own branded person-to-person and business-to-person payment services to eligible markets including Mexico, Guatemala, Honduras, the Dominican Republic, and El Salvador, as well as select countries in Southeast Asia, the European Union, and Africa.

    “Businesses want to innovate and expand quickly, but hurdles like technology development, licensing, and regulatory compliance often slow them down,” said Marcelo Theodoro, Chief Digital, Product & Marketing Officer at Intermex. “Our RaaS platform helps remove those barriers, giving partners a turnkey solution built on decades of experience and one of the strongest payout networks in Latin America.”

    The enhanced platform offers a customizable system that lets businesses create branded customer experiences across WhatsApp, mobile apps, and the web. The service is supported by appropriate licensing across U.S. jurisdictions, incorporating required know your customers and anti-money laundry compliance measures. Companies gain access to one of the largest payout networks in Latin America, supporting cash pickups, home deliveries, and direct bank deposits. The solution also provides integrated payment services, merchant account management, chargeback support, and advanced anti-fraud tools. Additionally, partners benefit from 24/7 bilingual customer support, business insights, and ongoing strategic guidance.

    “Our partners don’t have to build everything from scratch,” Theodoro added. “Through a simple API, we provide the infrastructure, licenses, payout networks, and even the support teams they need. Whether you’re a fintech, an employer, or a loyalty platform, we’re ready to help businesses move money across borders.”

    Companies interested in partnering with Intermex can learn more at www.intermexonline.com/partner-with-us#/.

    About Intermex
    Founded in 1994, Intermex applies proprietary technology to facilitate money transfers from select locations including the United States, Canada, Spain, Italy, the United Kingdom, and Germany to more than 60 countries, where available and subject to applicable regulations. The company facilitates digital money movement through its website and mobile app, as well as through a vast network of retail agents and company-operated stores. Headquartered in Miami, Florida, Intermex also operates international offices in Puebla, Mexico; Guatemala City, Guatemala; London, England; and Madrid, Spain. Learn more at www.intermexonline.com.

    Investor Relations Contact:
    Alex Sadowski
    Investor Relations Coordinator
    ir@intermexusa.com
    305-671-8000

    The MIL Network

  • MIL-OSI United Kingdom: Attorney General’s speech at Summer School in the Law of the Council of Europe.

    Source: United Kingdom – Executive Government & Departments

    Speech

    Attorney General’s speech at Summer School in the Law of the Council of Europe.

    The Attorney General delivered a speech ‘The Implementation of Strasbourg Court Judgments at National Level – Subsidiarity in Action’ at the Summer School in the Law of the Council of Europe.

    Introduction

    Thank you, Professor Garde.

    I am delighted to be addressing you this morning at the opening of what I am sure will be a fascinating Summer School on the Law of the Council of Europe.

    Your theme could not be more topical – the effectiveness of the Council of Europe in Tackling the Pressing Challenges of our times. 

    For what pressing challenges we face.

    Conflicts rage around the world, new threats are posed by climate change, growing inequality, mass migration, and by emerging artificial intelligence.

    The substantive challenges are numerous, global and complex.

    And they have to be addressed in an ever more challenging political environment of polarised public discourse fuelled by social media, tempting many towards the easy solutions offered by populist leaders.

    In light of these pressing challenges, we must renew our commitment to a strong international rules-based system, underpinned by an unequivocal commitment to the rule of law.

    This is why, since taking office, I have spoken repeatedly of my government’s commitment to the rule of law. Of how it will act as our lodestar.

    This should not be contentious. The Council of Europe’s body of constitutional experts, the Venice Commission for Democracy through Law, in their Rule of Law Checklist note that the rule of law is a concept of universal validity.

    The “need for universal adherence to and implementation of the Rule of Law at both the national and international levels” was endorsed by all Members States of the United Nations in 2005.

    Lord Bingham, one of the UK’s most distinguished judges, described the rule of law as “one of the greatest unifying factors—perhaps the greatest—and as an ideal worth striving for, in the interests of good government and peace, at home and in the world at large.”  

    What do we mean, though, by the rule of law in the Council of Europe context?

    It is not just rule of law; it clearly means much more than that in the European legal tradition.

    The Venice Commission, after long reflection on what conception of the rule of law fits best with European constitutional traditions, summarised the rule of law as the presence of six key elements:

    legality; legal certainty; the prohibition of arbitrariness; access to justice before independent and impartial courts; respect for human rights and non-discrimination; and equality before the law.

    This European conception of the rule of law was heavily influenced by Tom Bingham’s account in his wonderfully accessible book, The Rule of Law.

    A cornerstone of that rules-based system in Europe is of course the Council of Europe. Formed, you will recall, in the aftermath of World War Two. When we had seen the worst of humanity.

    But out of those horrors, a group of like-minded states came together with a pledge to uphold the rule of law, democracy and human rights.

    And for over 75 years, the Council, has stood as the conscience of Europe. It has sought to unite us around those shared values. 

    And those values have served us well. They have formed a foundation for European peace and prosperity.

    I consider that they remain the best hope of protecting us from the threats we face today, and those which are no doubt coming tomorrow. 

    At the heart of the Council of Europe system is the European Convention on Human Rights and Fundamental Freedoms.

    A shared statement of the rights, which all of us in the European family of nations hold dear.

    Based on the UN’s Universal Declaration of Human Rights and drafted by a British lawyer, David Maxwell Fyfe.

    The rights it contains reflect long-standing traditional common-law rights in our country. 

    The supranational system of human rights protection that has been built on those British foundations is one of the great achievements of the post-War period. 

    Its very durability demonstrates how well it has combined effective legal protection for the rights of individuals with a sensitivity to the importance of elected governments in our democratic societies.

    So my own view on one of the central questions that you will be considering at your Summer School is that the Council of Europe has proved extraordinarily effective at protecting the foundational European values of human rights, democracy and the rule of law. 

    It has also, for most of its 75 years, succeeded in uniting Europe around those shared values.

    This does not mean of course that every aspect of the Council of Europe must be preserved in aspic.  International organisations and their institutions must always evolve to ensure that they continue to serve their central purpose and that they retain the public confidence of every generation. 

    That means we must be prepared to build on our existing mechanisms, developing them where necessary to ensure that they can deal with today’s pressing challenges.

    Of course, we must always remain vigilant to guarantee that such updating strengthens the protection of our shared values rather than weakening them, whilst ensuring that such reform balances liberty with responsibility, individual rights with the public interest.

    There are many ways in which the operation of the Council of Europe’s institutions could be improved. 

    There is considerable scope, for example, to build on the recent explicit recognition of the principle of subsidiarity in the preamble to the ECHR – for example by helping states to better implement the Convention at national level so that the subsidiary role of the Court becomes less and less required as national protection of ECHR rights improves. 

    We should not be afraid – indeed, must not be afraid – of discussing how the European system for the protection of human rights can be improved to ensure that the public are confident that it continues to serve the central purpose on which everyone agrees: that human rights require effective legal protection. 

    Rather, we should be confident that we can demonstrate the value of this remarkable piece of institution-building and find imaginative ways of improving its operation in practice, which secures its democratic legitimacy, and ensures it is fit to meet the challenges we face, without weakening its protections.

    The execution of judgments, which I know is one of the themes you will be exploring at the Summer School, is one such area in which there is considerable scope to enhance the democratic legitimacy of the ECHR system, and on which the UK has taken a significant lead, so it is to this that I now turn.

    The Importance of Language

    First, I want to make a small but important point about language.

    The first step towards enhancing the democratic legitimacy of the ECHR is to talk about it in a way that is accessible and readily understandable by ordinary people.

    The phrase “the execution of judgments” fails that test.

    “Execution” is a lawyer’s term. The public’s understanding of execution is that it has something to do with capital punishment.

    Insofar as non-lawyers understand the meaning of the term, the execution of a court judgment sounds like a merely formal step in which the Government does what the court in its judgment has told it to do.

    As I will go on to explain, that does not reflect the reality following a judgment of the European Court of Human Rights, which very often leaves considerable scope to the democratic branches to decide how best to respond to the Court’s judgment.

    If we care about the democratic legitimacy of the ECHR, as we do and as we must, we therefore need a different language in which to talk about what happens following a finding of a violation by the European Court of Human Rights.

    Talking about the “implementation” of judgments is preferable to talking about their “execution”.

    But even “implementation” downplays the scope for democratic debate and political choice when a State considers how it should respond to an adverse judgment against it.

    It is important to frame the discussion in a way which makes clear to ordinary people the scope that usually remains for democratic debate when deciding how to respond.

    The obligation to comply with Court judgments

    In Article 46 of the Convention States, including the UK, have made an important commitment.  They have undertaken to abide by any final judgment of the European Court of Human Rights to which they are a party.

    This obligation, voluntarily entered into by all Council of Europe member states, is a crucial foundation of the international legal order in Europe.  It is key to ensuring the Convention is effective in practice. As the Venice Commission, in their report on the Polish judges case put it: ‘the right to individual petition would be illusory if a final binding judgment of the European Court of Human Rights remained unenforced.”

    Everyone agrees that it is a crucial feature of the rule of law that no-one is above the law.  That must include governments. If governments disregard decisions of the courts, then it undermines the rule of law.

    As the Venice Commissions puts it in their Rule of Law Checklist, “Judicial decisions are essential to the implementation of the Constitution and of legislation. The right to a fair trial and the Rule of Law in general would be devoid of any substance if judicial decisions were not executed.”

    The Convention recognises this, and Article 46 goes on to give the Committee of Ministers the responsibility for ensuring that judgments are given effect. It also includes a power for the Committee to refer cases back to the Court if they consider that a judgment is unclear, or that a Party is not abiding by their obligations.

    Subsidiarity in responding to Court judgments

    However, it is vital to understand the nature of the process that follows a final judgment of the Court of Human Rights that a state has violated the Convention.

    A recurring criticism of the European Court is that it erodes national sovereignty; that when it finds States in breach of the Convention, there is a democratic deficit. Too often their judgments are mischaracterised as an anti-democratic exercise in dictation from abroad.

    Confidence risks being undermined by misconceptions about the relationship between the European court and state parties.

    I therefore want to emphasise the critical role that national authorities have in implementing those judgments.  

    The principle of subsidiarity, captured by Protocol 15 which formally introduced the concept into the preamble to the Convention, means that States have primary responsibility for implementing the Convention rights into their national system.

    It states, ‘the High Contracting Parties, in accordance with the principle of subsidiarity, have the primary responsibility to secure the rights and freedoms defined in this Convention’.  This recognises that it is domestic authorities with the power and understanding to ensure rights compliance in each country, in light of their cultural values.

    That means that States have to have an effective legal framework which gives practical and meaningful effect to those rights.  In the UK that is the Human Rights Act.

    But it also means that, following a finding of a violation of Convention rights by the Court, states also have the primary responsibility to find a way to give effect to those rulings in a way that works for their particular national context.

    The responsibility for implementing judgments is therefore a shared responsibility between the branches of the State, including the democratically elected branches. This ensures that no judgment ends in Strasbourg. That it finds full, timely implementation at a national level.

    It goes hand in hand with the margin of appreciation – the recognition from the European Court that different countries have different legal, cultural, and social contexts, and therefore, they should be given flexibility in how they interpret and apply the Convention rights.

    Subsidiarity is not subordination; the European Court institutions must still ensure that national authorities keep to their obligations, but the main responsibility for working out how to do so rests with the states, in accordance with their democratic processes. Balancing national sovereignty with respect for universal rights.      

    Subsidiarity is a vital link between the mutually reinforcing principles of democracy, human rights and the rule of law.

    The process for the implementation of judgments is an example of subsidiarity in action: all arms of the state, and civil society, playing their part in deciding the most appropriate way of giving effect to the rulings of the European court.

    UK processes

    Before saying a little about how the UK gives effect to judgments from the European Court, it is worth recalling that the UK has the lowest per capita rate of violations of any party. Last year there were just three judgments against the UK, one finding a violation, one finding no violation and one which was settled. So perhaps with less adverse judgments, we have an easier job ensuring that they are implemented.

    But even with that concession in mind, the UK does implement the judgements of the European Court with a current closure rate of around 98%.

    I want to now offer some reflections on our approach and why I see it as subsidiarity in action.

    The European Convention is given further effect in domestic law through the architecture of the Human Rights Act 1998. That architecture includes a power in section 10 to respond to adverse judgments from the courts – both the European Court of Human Rights and domestic courts.

    This enables the Executive a ‘fast track’ way of introducing legislation into Parliament to remedy the breach of Convention rights which the court has found. How to respond to any adverse decision therefore falls to the democratically elected government to decide.

    But as well as the Executive, the legal framework of the Human Rights Act, and the institutional human rights machinery that has been built in the UK, ensures that both Parliament and civil society also play their part.

    The Joint Committee on Human Rights is the Parliamentary Committee responsible for examining matters relating to human rights. It scrutinises government legislation to ensure that it is compatible with human rights. It also systematically scrutinises the Government’s response to human rights judgments of courts. Where that response is by way of a Remedial Order, the Committee’s terms of reference require it to report on any Remedial Order made under the Human Rights Act, prior to consideration by both Houses of Parliament.

    As part of this process, the Committee often calls for evidence and welcomes input from civil society.

    This system allows for considerable democratic input into the process of responding to a Court judgment. It also offers a high level of democratic scrutiny, ensuring action is taken in response to adverse judgments to protect rights, but recognising that there might be a range of possible responses which satisfy the judgment. It therefore supports the rule of law values of transparency and accountability.

    Let me illustrate with an example. In May 2021 the Grand Chamber found a violation of Articles 8 and 10 in the case of Big Brother Watch and Others v the UK.

    These cases each challenged elements of the UK’s investigatory powers regime. At the time of the judgment, enhanced safeguards had already been introduced, however, there remained issues with Convention compliance.

    The then Government laid before Parliament a proposed Remedial Order to introduce further safeguards into the regime, in particular to offer further protections for journalistic material.

    The Joint Committee on Human Rights published their report, recommending one change to further protect rights. This was accepted by Government. Representations were also received from the Investigatory Powers Commissioner’s Office and the UK Intelligence Community, which were also taken into account.

    The Remedial Order was passed by Parliament and amended the regime to better safeguard the rights of all. An action report of the steps taken was sent to the Committee of Ministers, who closed their supervision of the judgment.

    This is just one example of how the democratically elected government, and Parliament have responded to a judgment from the European Court to ensure not just rights compliance, but rights compliance in the national interest, and on the terms of a sovereign Parliament. The process for responding to a judgment of the Court is subsidiarity in action. Understanding and explaining it as such is vital for maintaining confidence in the credibility and legitimacy of the Convention.

    Conclusion

    We must counter the common perception of the Court’s judgments as a foreign imposition on our national sovereignty and reflect the more nuanced reality. The proper implementation of judgments is an essential pillar of the rule of law.

    But it is also subsidiarity in action; the national authorities, including the democratic branches, debating and deciding how best to respond to a Court judgment, and then working in partnership with the Council of Europe institutions to give effect to our shared values.

    I therefore welcome the focus of this Summer School on this very important issue. There is no justice for victims if judgments are not enforced, because a judgment without execution is a right without remedy. But to secure the public’s confidence in the democratic legitimacy of the system, institutional mechanisms and processes must be developed to ensure meaningful opportunities for political debate about how best to respond to Court judgments.

    Updates to this page

    Published 8 July 2025

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Death of Lord Tebbit

    Source: Traditional Unionist Voice – Northern Ireland

    Statement by TUV Leader Jim Allister KC MP:

    “I am deeply saddened to learn of the passing of Lord Tebbit.

    “His personal courage and unyielding determination following the IRA’s brutal Brighton bombing in 1984 revealed the measure of the man. The steadfast devotion he showed to his beloved wife — left paralysed by Republican terrorists — was a testimony to all that is noble in the human spirit when confronted by unrelenting evil.

    “That some, even in the hour of his death, choose to criticise his resolute opposition to the wickedness of the IRA says more about them than about him. Their disdain for innocent victims and willingness to trample justice underfoot in the name of appeasement is shameful.

    “I extend my sincere condolences to Lord Tebbit’s family and trust that they will know comfort and sustaining grace in the days to come.”

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Government response to the Post Office Horizon IT Inquiry report

    Source: United Kingdom – Executive Government & Departments

    Government response

    Government response to the Post Office Horizon IT Inquiry report

    The Business and Trade Secretary and the Post Office Minister have issued statements in response to the publication of the Post Office Horizon IT Inquiry’s report.

    Business Secretary, Jonathan Reynolds, said:  

    The publication of the Post Office Horizon IT Inquiry’s report today by Sir Wyn and his team marks an important milestone for subpostmasters and their families.

    I welcome the publication today and am committed to ensuring wronged subpostmasters are given full, fair and prompt redress.

    The recommendations contained in Sir Wyn’s report require careful reflection, including on further action to complete the redress schemes. Government will promptly respond to the recommendations in full in Parliament.

    Post Office Minister, Gareth Thomas, said:

    I welcome the Inquiry’s publication today and pay tribute to Sir Wyn and his team for their comprehensive and penetrating work.

    We must never lose sight of the Horizon Scandal’s human impact on postmasters and their families, which the Inquiry has highlighted so well.

    Sir Wyn’s report highlights a series of failings by the Post Office and various governments. His recommendations are immensely helpful as a guide for what is needed to finish the job and we will respond in full to Parliament after carefully considering them.

    Updates to this page

    Published 8 July 2025

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Championing maritime excellence: MCA leads UK Flag Forum 2025

    Source: United Kingdom – Executive Government & Departments

    Press release

    Championing maritime excellence: MCA leads UK Flag Forum 2025

    The Maritime and Coastguard Agency hosts this year’s UK Flag Forum event at the Queen Elizabeth II Centre in London.

    Autonomous vessels and alternative fuels are among the key maritime topics being discussed by ship owners, operators and regulators at this year’s UK Flag Forum.

    Hosted by the Maritime and Coastguard Agency at London’s Queen Elizabeth II Centre today (8 July), the event brings key figures from across the global shipping industry together to discuss the UK flag and strengthen its position as a world-leading flag state.

    The UK Flag Forum is a platform for shipowners, operators, regulators and policymakers to share insight and discuss issues and opportunities, including seafarer training, decarbonisation and navigational safety.

    The event was formally opened this morning by Virginia McVea, CEO of the Maritime and Coastguard Agency (MCA).

    Lord Simon Stevens, Chair of the MCA, provided a welcome address before a panel discussion on the Department for Transport’s Maritime Decarbonisations Strategy.

    Panellists include Deputy Director of UKSHORE Eamonn Beirne, Senior Sustainability Advisor at British Ports Association Rhona MacDonald and Philip Fullerton, Managing Director at Northern Marine Group Ltd.

    MCA Chief Examiner and Head of Seafarer Technical Delivery Ajit Jacob has been leading the day’s first seminar session on Seafarer Training, with MCA’s Maritime Autonomy Team Leader Katrina Kemp presenting on Maritime Autonomous Surface Ships (MASS).

    MCA’s Acting Director of Technical Operations Prasad Panicker has been speaking on Approvals for Alternative Fuels,

    This afternoon MCA Director of Maritime Futures Keith Johnstone will focus on Decarbonisation, with Deputy Director of Regulations and Standards Gwilym Stone leading a Near Coastal Workshop.

    MCA Assistant Director for UK Technical Services Navigation Richard Bell will be discussing Navigational Safety.

    Maritime Minister Mike Kane said: 

    I am thrilled to join the MCA at this year’s UK Flag Forum, which is so crucial in bringing key players in the sector together to discuss the issues facing the maritime industry.

    We are committed to the UK becoming a clean energy superpower, which is why earlier this year we set out a course to net zero shipping by 2050. Only by working together can we tackle the impact of shipping on our climate, create a greener sector, and deliver on our shared ambitions.

    MCA Director of UK Customer Maritime Services Lars Lippuner said: 

    The UK Flag Forum remains a vital platform for shaping the future of the UK maritime sector. By bringing together key stakeholders, we foster collaboration and drive meaningful progress during what is an exciting and pivotal time for our industry.

    Now more than ever, working together is essential, and we look forward to engaging with our customers; listening, discussing, and learning from them today.

    As both hosts and speakers, the MCA is proud to provide a platform for open discussion at the UK Flag Forum, with a strong emphasis on upholding the excellence of our world-class flag and the important work it represents.

    The event will be closed with a keynote speech by the Minister.

    Updates to this page

    Published 8 July 2025

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Certification Officer Annual Report 2024-2025

    Source: United Kingdom – Executive Government & Departments

    Press release

    Certification Officer Annual Report 2024-2025

    Annual Report to the Secretary of State for Business and Trade and the Chair of ACAS on the activities of the Certification Officer

    Certification Officer for Trade Unions and Employers’ Associations: press announcement

    The annual report of the Certification Officer, Sarah Bedwell, was laid before Parliament on 7 July 2025. The report describes the work of the Certification Officer in 2024/25 and includes statistical information relating to trade unions and employers’ associations for 2023 and 2024.

    Lists of trade unions and employers’ associations

    There were changes to the list of trade unions on the Certification Officer’s list with 4 trade unions being removed and 4 new organisations being added. Therefore, the total number of listed trade unions was 128, the same number as in the previous reporting year. The number of employers’ associations remained stable at 36 with no changes.

    Trade union membership and finances

    Reported trade union membership increased by 21.8% – from 5.5 million in 2022-2023 to 6.7 million in 2023-2024. However, this was mainly because of the inclusion of Unite the Union’s membership of 1.2 million which was not included last year.

    Total assets of trade unions saw a decrease of 1.3% from £2.30 billion to £2.27 billion.

    Political funds

    Twenty unions reported on their political funds. The total amount held in those political funds was £35.8 million, an increase of 7.8% compared to the previous year.

    Complaints

    The Certification Officer issued decisions on 13 complaints from members against their trade unions. Of these, 4 complaints were withdrawn by the applicants, 3 were struck out, 5 were dismissed following hearings and 1 was upheld with 1 enforcement order being made.

    Powers from the Trade Union Act 2016

    The amendments brought in by The Trade Union Act 2016 mean that trade unions and employers’ associations are required to pay a levy to fund the costs of the Certification Officer’s office. The second levy collection was completed in the reporting year.

    The total costs which need to be funded, for this year, through the third levy are £615,146, an increase on last year’s figure of £607,444 due to implementing the agreed public sector pay increase.

    The amendments also allow the Certification Officer to:

    • Consider whether an organisation has breached certain statutory responsibilities without having first received a complaint from a member of that organisation or another eligible party.
    • Impose a financial penalty order or conditional financial penalty order where she finds that an organisation has breached its statutory responsibilities and/or its rules.

    There was one breach of the statutory election requirements which was brought to the Certification Officer’s attention by the trade union concerned. The Certification Officer agreed that the breach had occurred and made an order to remedy the breach.

    The Certification Officer did not see cause to make any financial penalty or conditional financial penalty order in relation to any of the beaches that she found (either arising from members’ complaints or otherwise).

    Notes to editors:

    • The Certification Officer is the independent regulator for trade unions, appointed by the Secretary of State for Business and Trade. Sarah Bedwell was appointed to the post on 1 January 2018 and retired on 31 May 2025. Michael Kidd was appointed as Interim Certification Officer from 1 June 2025.

    • All figures are taken from the annual returns received from organisations during the reporting year.

    Please direct any press enquiries to:

    0330 109 3602, info@certoffice.org

    Updates to this page

    Published 8 July 2025

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: York Talk Money fortnight to help residents save thousands

    Source: City of York

    York residents can access a wealth of information and support that could save them thousands of pounds during York Talk Money fortnight, running from 7 to 18 July.

    Run by City of York Council and partners across the city, including Citizens Advice, Peasholme Charity, Age UK, York Energy Advice and OCAY, the regular event aims to help people who are struggling financially by sharing information and advice, and signposting to local help and support.

    York Talk Money aims to help York residents:

    • Get all the help they are entitled to
    • Reduce their outgoings as much as possible
    • Get advice if they need assistance

    The support available includes a new weekly drop-in with the non-profit Community First Credit Union.

    Residents can find out about the range of services, including back to school and Christmas savings accounts, affordable and fair loans and budgeting accounts. Pop along to Clements Hall, Nunthorpe Road, from 9.15am to 10.45am, or Marjorie Waite Court, Clifton, from 1pm to 3pm every Tuesday throughout July to find out more.

    National Energy Advice and Yorkshire Water will also be on hand at two welcoming and informative community events to support families and individuals with practical energy advice, resources, and free giveaways on Tuesday 8 July at The Gateway Centre, Front Street, from 10am to midday and Marjorie Waite Court Community Café from 1pm to 3pm.

    And people can find out more about using the council’s benefits calculator to find out what benefits they or residents they’re working with might be eligible for at an online teams webinar on Wednesday, July 16 from 12.30pm to 1.30pm. Booking is required, visit the webinar booking page to secure your place. 

    Cllr Katie Lomas, the council’s Executive Member with responsibility for Financial Inclusion, said:

    We know that the cost of living crisis is affecting many of us, but there is a lot of help, advice and support available locally to help you make the most of your money.

    “Getting the help you’re entitled to really can make a difference of thousands of pounds. Following our Pension Credit Take Up campaign, over 231 pensioners are now claiming over £1.7 million in Pension Credit, and passported support.

    “I’d urge anyone who’s facing financial hardship or worried about money to find out what help is available to them via our or local advice and support services, including York Talk Money Fortnight.”

    One York resident who received advice and support from Age UK York to claim Attendance Allowance, as part of the York Talk Money initiative, said:

    “A lot of pressure has now been taken off me. I was so cold this winter that I turned the heating on for the first time and felt an awful lot better. I don’t need to worry about turning the heating on anymore. Without your help I wouldn’t be in the position I am in today.”

    General advice on how to get the help you’re entitled to, reduce your outgoings and get further support is available at Live Well York or our Benefits Calculator.

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: City of York Council asked to adopt new Equity, Diversity and Inclusion Strategy

    Source: City of York

    City of York Council’s Executive will be asked to approve a new Equity, Diversity and Inclusion (EDI) Strategy for the council later this month [15 July].

    The strategy sets out the council’s approach to EDI, supporting the Council Plan priority on Equalities and Human Rights to provide equality of opportunity for all and ensure that residents and visitors can benefit from the city and its strengths.

    The development of the strategy is linked to other recent areas of action including the re-establishment of the Human Rights & Equalities Board, the council’s adoption of the Social Model of Disability and its Anti-Racism Action Plan and Gypsy and Traveller Action Plan.

    It also builds on the city’s designation and partnership working around York’s status as a City of Sanctuary, Human Rights City and pledge to be an Anti-Racist City, together with growing cross-partnership strengths in these areas.

    The strategy aims to help the council deliver services that are equally accessible to all customers; fulfil its obligations to consider how its work affects diverse communities and to reduce disadvantage for people with protected characteristics.

    The strategy also sets out the council’s approach to EDI in the workplace and will help guide staff in their day-to-day work.

    The draft strategy was updated in response to feedback from a public consultation earlier in the year, which received approximately 500 responses from residents and organisations.

    The consultation included dedicated focus groups with people with protected characteristics, including people with learning difficulties; older people; young adults; neurodivergent people; and members of the LGBTQIA+ community.

    Of the responses received, one in five respondents reported having experienced or witnessed intolerance or discrimination from the council, with three out of four agreeing that the council’s services are accessible to all its communities.

    A draft action plan has been created on each of the key elements of the strategy to ensure timely and measurable progress is made.

    Councillor Katie Lomas, Executive Member for Finance, Performance, Major Projects, Human Rights, Equality and Inclusion, said:

    We want York to be a place that celebrates diversity and includes everybody in the life of the city by ensuring they have access to the same opportunities and experiences.

    “Equalities and Human Rights are a core commitment within our Council Plan. We’re committed to achieving continuous improvement and equity across all our services and functions.

    “While the results of the recent consultation show that we still have more work to do to ensure that all the members of York’s diverse communities feel seen and heard, we look forward to continuing to work with colleagues, partners, community groups and local people to tackle discrimination, harassment and victimisation in all its forms.”

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: COAST Sunderland launches environmental campaign encouraging local communities to ‘Explore with Care’

    Source: City of Sunderland

    With school holidays approaching and Summer weather on its way, COAST Sunderland is launching a new initiative to encourage residents to reconnect with the stunning coastline on their doorstep – but to do so with care.

    With school holidays approaching and Summer weather on its way, COAST Sunderland is launching a new initiative to encourage residents to reconnect with the stunning coastline on their doorstep – but to do so with care.

    Backed by Sunderland City Council, COAST Sunderland is a dedicated initiative protecting the iconic cliffs, beaches, and wildlife that make the area from Whitburn to Ryhope such an outstanding area of natural beauty to live and explore. The project hopes to raise new awareness by asking local communities to follow the Coast Code and to ‘Explore with Care’.

    Launched in 2017 and funded through developer contributions, COAST Sunderland works year-round to raise awareness of the area’s unique habitats, support local biodiversity and tackle key issues affecting the coastal zone — from litter and erosion to habitat and bird disturbance.

    The ‘Explore with Care’ campaign highlights everyday actions that can help preserve Sunderland’s unique coastal environment for generations to come. From avoiding dog fouling and sticking to marked paths, to keeping dogs under control near feeding and resting birds, the focus is on encouraging small behaviour changes that have a big impact.

    Cllr Lindsey Leonard, Cabinet Member for Environment, Transport and Net Zero Portfolio Holder at Sunderland City Council, said: “Sunderland has a fantastic, natural coastline and it is crucial that we work together to protect it for years to come. The invaluable support and collaborative efforts of the COAST Sunderland team means visitors and residents can all appreciate our coastline with care – protecting the natural landscape whilst also having a great day out at the seaside – a win-win for everyone!”

    Sunderland’s coastline is home to specially conserved animal and plant species under threat from human disturbance, including a range of wading bird species (also known as ‘waders’) during the autumn and winter months. Bird species include Oystercatchers, Purple Sandpipers, Turnstones and Europe’s largest wading bird, the Curlew. The COAST Code has been developed locally for residents and visitors alike to reduce the amount of bird disturbance on the coast. The steps are:

    1. Look out for birds
    2. Give them space
    3. Are they reacting to you or your dog?
    4. If yes, please give more space

    Becky Lakin, Coast Project Officer at COAST Sunderland said: “We want people to get out and enjoy the coast this Summer – it’s one of Sunderland’s greatest assets. However, many residents and visitors don’t realise that things like straying from marked paths or disturbing feeding birds can seriously damage our rare plant life and put coastal wildlife under stress. That’s where the ‘Explore with Care’ campaign and COAST Code come in. They help reinforce small, sustainable habits that will protect our beautiful coastline for many more years to come.”

    COAST is leading several free educational activities throughout the Summer holidays, to highlight how people can enjoy Sunderland’s coastline with care. Upcoming events include a marine mammal ID session on World Conservation Day (Monday 28 July) at Roker Pier. The COAST team are also hosting interactive sessions throughout the Summer at Sunderland Museum & Winter Gardens, starting on Wednesday 30 July from 1pm – 3pm, concluding with a Guided Rock Pooling Session on Wednesday 27 August.

    Future plans for the project include working with schools, local groups and volunteers to run guided coastal walks, beach cleans, and conservation workshops to deepen community understanding and stewardship of this precious landscape.

    COAST Sunderland’s ‘Explore with Care’ campaign will appear across outdoor billboards, social media, local radio, and in community spaces throughout the summer. Leaflets with tips and facts are also being distributed, supported by detailed guidance on the COAST Sunderland website.

    For more information on the campaign, or to find out more about the Coast Code and upcoming events visit: https://sunderland.coastproject.org

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Anti-discrimination campaign brings city together

    Source: City of Leeds

    The campaign, which takes a stand against all forms of discrimination, has been running for the past month with the unifying message of “What makes us different makes us Leeds”.

    With posters across the city and social media activity the Leeds City Council campaign has communicated non-tolerance for misogyny, racism, anti-Muslim prejudice, antisemitism, ageism, homophobia, biphobia and transphobia, and disability discrimination.

    Councillor Mary Harland, Leeds City Council’s executive member for communities, customer service and community safety, and Councillor Fiona Venner, executive member for equality, health and wellbeing, said: “It’s been wonderful to finally see this campaign come to life across the city, making sure that everyone knows Leeds does not tolerate discrimination in any form. We’ve had a lot of positive feedback from communities and residents, and any negative comments we receive only highlight the importance of continuing this work. 

    “Working towards strengthening social cohesion in our city is vital to ensure everyone feels like they belong and that they are and feel safe. Our ambition is for Leeds to be the best city in the UK and at the heart of this is our mission to tackle inequality. 

    “We will continue to work with all our communities to tackle discrimination and build a safer and stronger Leeds.” 

    The Leeds Anchor Network which brings together 14 of the city’s largest employers – including the council, NHS trusts, higher and further education, culture, and utilities, has also supported the campaign.

    Professor Peter Slee, chair of the Leeds Anchor Network and Vice Chancellor of Leeds Beckett University, said: “The Leeds Anchor Network welcomes this campaign. Leeds is a city built on communities, partnership and collaboration, and this strength is reflected in our network. We are committed to inclusion, to listening to our communities, and to working with everyone in the city for a united approach to inclusive growth.”

    Speaking up in support is also Leeds Older People’s Forum, a network of third sector organisations working with and for older people.

    Jo Volpe, chief executive of Leeds Older People’s Forum, said: “Leeds Older People’s Forum is proud to support this important campaign from Leeds City Council. Ageism can lead to real harm—excluding older people from opportunities, reinforcing damaging stereotypes, and increasing loneliness and isolation. Our communities need this kind of support to challenge discrimination and promote respect across all ages. We all have a role to play in making Leeds a city where everyone feels valued.”

    Read more about the campaign at leeds.gov.uk/strongerleeds

    ENDS

    The campaign has sourced funding from the community recovery fund: Community Recovery Fund: Guidance – GOV.UK. This is a pot made available to areas who experienced unrest in 2024, and can be used for a range of things, including “To reduce the risk of further disorder in the future” and “To rebuild social trust and promote cohesion between communities”.

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Chris Boardman reappointed as Chair for Sport England.

    Source: United Kingdom – Executive Government & Departments

    News story

    Chris Boardman reappointed as Chair for Sport England.

    The Secretary of State has reappointed Chris Boardman as Chair for Sport England for a term of four years from 22 July 2025 to 21 July 2029.

    Chris Boardman

    In 1992, Chris Boardman won Britain’s first Olympic cycling gold medal in 73 years. He went on to claim several world titles and wore the leader’s jersey in the Tour de France on three occasions before retiring in 2000.

    After his sporting career, Chris played a pivotal role in transforming British Cycling into a global powerhouse and founded Boardman Bikes. The eponymous brand quickly became Britain’s fastest-growing bike company and expanded its reach to over 80 countries. Chris’s passion for cycling evolved into a broader commitment to promoting active travel and helping people integrate physical activity into their daily lives. Collaborating closely with Regional Mayor Andy Burnham, he became Greater Manchester’s first Active Travel Commissioner. He later established Active Travel England on behalf of Prime Minister Boris Johnson.

    In addition to his role as England’s Active Travel Commissioner, Chris has chaired Sport England for the past four years, guiding the sector through the challenges of the pandemic and championing efforts to make sport and physical activity accessible to everyone—regardless of background or income.

    Updates to this page

    Published 8 July 2025

    MIL OSI United Kingdom

  • MIL-OSI: MEXC Ventures Hosts Successful “Kickstart Your Future” Event at UNSW, Marking Australian Market Entry

    Source: GlobeNewswire (MIL-OSI)

    VICTORIA, Seychelles, July 08, 2025 (GLOBE NEWSWIRE) — MEXC Ventures successfully concluded its inaugural Australian event, “Kickstart Your Future at MEXC Ventures,” held at the University of New South Wales Roundhouse on 19 June 2025. The Web3 career-focused gathering brought together over 120 students, graduates, and industry professionals, marking a significant milestone in the global exchange’s expansion into the Australian market.

    Exceptional Student Response and Engagement
    The event exceeded expectations with remarkable attendance figures, drawing more participants than initially registered on the platform. More than 130 attended the event with high enthusiasm. The overwhelmingly positive response demonstrated a strong appetite among Australian students for Web3 career opportunities.

    “The turnout and engagement were incredible,” noted event organizers. “Students came with genuine interest in building careers in Web3, and many stayed long after the formal presentations to continue networking and discussions.”

    Industry Expertise Takes Center Stage
    The event featured three prominent speakers who delivered compelling presentations on blockchain fundamentals and career pathways. John, founder of Bitcoin Sydney, presented on Bitcoin principles including decentralization and financial sovereignty. Bob, founder of ETH Sydney, explored how Ethereum powers innovation across the ecosystem. Ray, a UNSW lecturer specializing in blockchain and fintech, provided academic insights into emerging technologies and career opportunities.

    The diverse panel discussions emphasized that Web3 offers career paths beyond traditional coding roles, spanning marketing, community management, governance, research, and content creation.

    Community Building and Brand Presence
    MEXC Ventures established a strong local presence through strategic brand activations, including custom Australian-themed merchandise featuring koala keyrings, prominent logo placement, and a dedicated photo wall. MEXC Ventures representative delivered an engaging presentation about career opportunities, emphasizing the global nature of Web3 work and the company’s commitment to empowering the next generation of blockchain talent.

    Attendees praised the event’s organization, quality of food and beverages, and the caliber of panel discussions, with many expressing interest in future MEXC Ventures initiatives.

    Talent Recruitment Initiative Launched
    Following the event’s success, MEXC Ventures opened student volunteer and ambassador recruitment for Australia, receiving numerous applications from interested participants. The company also highlighted its IgniteX initiative, a social impact program supporting blockchain education and developer empowerment, including the recently launched partnership with Superteam for the IgniteX Solana Talent Lab.

    Building Australia’s Web3 Future
    The event’s success signals strong momentum for MEXC Ventures’ Australian operations, with plans to expand programming and deepen university partnerships across the region. The enthusiastic student response and high-quality industry engagement demonstrate the readiness of Australia’s academic community to embrace Web3 innovation.

    “This is just the beginning,” said MEXC Ventures representatives. “We’re committed to creating more opportunities for Australian students to engage with the global Web3 ecosystem and build meaningful careers in this space.”

    About MEXC Ventures
    MEXC Ventures is a comprehensive fund under MEXC dedicated to driving innovation in the cryptocurrency sector through investments in L1/L2 ecosystems, strategic investments, M&A and incubation. Upholding the principle of “Empowering Growth Through Synergy,” MEXC Ventures is committed to supporting innovative ideas and active builders in crypto.

    MEXC Ventures is an investor and supporter of TON and Aptos, looking forward to staying at the forefront of TON and Aptos’ innovations and actively engaging with builders to drive ecosystem growth.

    For more information, visit: MEXC Ventures Website

    Photos accompanying this announcement are available at:

    https://www.globenewswire.com/NewsRoom/AttachmentNg/4f9e0774-c26c-4a61-832e-7c4fafc92cce

    https://www.globenewswire.com/NewsRoom/AttachmentNg/9c1aca19-362f-467b-8a65-6a56f7488b39

    https://www.globenewswire.com/NewsRoom/AttachmentNg/7ff52ac7-6d34-44ea-899d-50ccbf473036

    https://www.globenewswire.com/NewsRoom/AttachmentNg/736db56d-aaa3-46d6-8085-200150f0c698

    The MIL Network

  • MIL-OSI United Kingdom: Ministry of Justice praises Plymouth Youth Justice Service for ‘exceptional performance’

    Source: City of Plymouth

    Plymouth City Council’s Youth Justice Service has received outstanding recognition from the Ministry of Justice for their exceptional performance in delivering the Turnaround Programme, earning praise for their ‘dedication, professionalism and commitment to improving outcomes for children and their families’.

    The service has been congratulated for successfully diverting children from the youth justice system through innovative early intervention and prevention work that focuses on building meaningful relationships with young people to help them understand healthy relationships, peer dynamics, and the impact of their actions on victims.

    The Turnaround Programme focuses on early intervention and prevention work, which includes relationship building with children to understand healthy relationships, peer relationships, impact on victims, and understanding reasons why children display concerning behaviour and become in conflict with the law.

    It diverts children from the youth justice system at the earliest opportunity. The programme forms part of the wider early help and targeted support offer from Plymouth City Council’s Children’s Services team.

    The success has been remarkable, with the team not only working with the required number of children but being oversubscribed due to the exceptional value of their interventions. The Ministry of Justice contacted the service directly to congratulate staff on their innovative and creative approach to this vital work.

    Councillor Jemima Laing, Cabinet Member for Children’s Social Care, said: “The programme is helping to achieve positive outcomes for children with the aim of preventing them going on to offend.

    “It helps build on work already done to ensure all children on the cusp of the youth justice system are consistently offered the opportunity for support.

    “This work is crucial, and due to Plymouth’s contribution, the Ministry of Justice has exceeded its aim to support just over 17,000 children and young people in the UK over the past three years and there have already been some significant and positive changes achieved for communities.

    “I would like to congratulate the service, and to be recognised by the Ministry of Justice is a huge achievement, it shines a light on all of the great work they are doing to help our young people on to the right path.”

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: You’re Invited! Central Winchester Regeneration drop-in events

    Source: City of Winchester


    Central Winchester Regeneration’s Development Partner: Jigsaw- Partnerships and Places, will be in Winchester later this month and they’d love to see you!

    Would you like an update on their plans, or do you have any questions about the progress of the project? Jigsaw has been developing some ideas and they would like to share some early thoughts with you.

    They are hosting two drop-in information events at The Guildhall:

    Thursday 17 July 2-7pm

    and

    Friday 18 July 10am-2pm

    The Courtyard, The Guildhall, Winchester, SO23 9GH

    Everyone is welcome to attend to find out the latest update on the project; learn what happens next, give your feedback on early plans and meet members of the project team.

    There is no need to book- just turn up!

    Caption

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Fostering for Wolverhampton hosts annual conference

    Source: City of Wolverhampton

    This year’s conference focused on wellbeing, recognising the emotional and physical demands of fostering and the importance of supporting foster parents so they can continue to provide safe, stable, and loving homes.

    The event featured a range of sessions designed to offer practical tools, emotional support, and shared experiences. Highlights included a powerful talk on menopause and its impact on family life, including a male perspective, a breathwork reset session led by Little Earth, and an interactive workshop on stress and coping strategies delivered by Wolves Foundation.

    The conference also provided a space for foster parents to connect, reflect, and feel valued – reinforcing the message that when foster parents thrive, so do the children they care for.

    Alison Hinds, the City of Wolverhampton Council’s Director of Children’s Services, opened the event, thanking foster parents for their dedication and resilience. The day was designed not only to support current foster parents but also to show potential new foster parents the strong network and resources available to them.

    Councillor Jacqui Coogan, Cabinet Member for Children, Young People and Education, said: “We know that fostering is both incredibly rewarding and incredibly demanding. That’s why we’re committed to supporting our foster parents every step of the way – through training, wellbeing support, and events like this.

    “This conference is about more than just information-sharing. It’s about building confidence, strengthening connections, and showing our appreciation for the amazing work foster parents do every single day.”

    Fostering for Wolverhampton welcomes foster parents from all walks of life. To foster, you must live within 20 miles of Wolverhampton, have a spare bedroom, and the time and compassion to care for a child or young person.

    Foster parents receive full training, ongoing support, and a regular, tax-exempt fee and allowance. A buddy system is also in place to support new foster parents, along with regular social events and 24/7 advice.

    To find out more about fostering, visit Fostering for Wolverhampton or call the team on 01902 551133.

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: The growing case for trees on farms Land managers, farmers, foresters, researchers, and policy makers will gather in Aberdeen for a landmark event to explore how integrating more trees into farmland could play a pivotal role in tackling climate change, improving biodiversity, and supporting resilient rural economies.

    Source: University of Aberdeen

    Tree planting at Glensaugh farm (James Hutton Institute)

    Land managers, farmers, foresters, researchers, and policy makers will gather in Aberdeen for a landmark event to explore how integrating more trees into farmland could play a pivotal role in tackling climate change, improving biodiversity, and supporting resilient rural economies.
    Agroforestry—the practice of integrating trees into crop or livestock systems—offers a range of benefits from improved water cycling and the enrichment of soil health to carbon sequestration and a reduction in erosion.
    Trees can also provide shade and shelter for animals, act as windbreaks and create habitats for pollinators and wildlife.
    The Farm Woodland Forum Annual Meeting, organised in partnership with the University of Aberdeen and The James Hutton Institute, will be held in Aberdeen for the first time in 30 years.
    Themed ‘The role of agroforestry in integrated land management’, the eventwill highlight how trees can work alongside farming to deliver both economic and environmental benefits.
    Dr Josie Geris, Reader in Hydrology at the University and lead host of the conference said: “Farmland trees have often been overlooked in traditional agricultural models, this event will shine a spotlight on their increasing importance in addressing the challenges of climate change, biodiversity loss, and food production.
    “In addition to increasing environmental and farm resilience, well-planned tree planting can deliver wide-ranging benefits, including timber, fruit, fodder and biomass production, alongside other alternative income and energy sources.”
    The conference will take place July 9–10, 2025, starting with a full day of talks and poster sessions at King’s College Conference Centre, followed by a field visit to Glensaugh Research Farm, home of the James Hutton institute’s climate-positive farming initiative where participants will explore long-term agroforestry trials and tree-based climate resilience measures in action.
    Highlights include first-hand insights from farmers integrating trees into livestock and arable systems, research on the role of trees in reducing flooding, improving soil health, and enhancing biodiversity, updates on policy and payment schemes supporting farm woodland expansion and a look at decision-support tools helping farmers plan tree planting to fit their land and business goals.
    Dr Julie Rostan, whose UKRI Treescapes programme funded research with colleagues at the University of Aberdeen and James Hutton Institute has looked at balancing socio-economic and environmental factors of the potential for agroforestry across Scotland, will showcase her work at the event.
    She said: “The research has developed farmed based knowledge and practical tools that can help with decision making about integrating trees into farms for a more strategic approach to planting which can be tailored to individual needs whether it is improving benefits for livestock or farm ecosystem health.”
    “Understanding of the importance and challenges to integrate tree planting into farmland is gaining momentum and this conference is an opportunity to hear from practitioners already seeing the benefits, as well as scientists developing the tools and knowledge to support wider adoption, and third sector organisations that facilitate this.
    “Agroforestry is not about choosing between trees and food production. It’s about designing systems where both thrive.”
    Glensaugh Research Farm has several areas of mature agroforestry which were planted in 1988 to explore the production benefits of integrating trees within a livestock farming system. These were planted as part of a National Network of seven UK research sites, co-ordinated by the Farm Woodland Forum (then the UK Agroforestry Forum). Three species were selected (Scots Pine, Hybrid Larch and Sycamore) and planted at a range of different densities, which allowed comparison of these differences on a range of factors including tree growth, grass production and livestock output. Findings from this have contributed significantly to advancing agroforestry research and knowledge.
    The project continues to provide a living demonstration of the longer-term practicalities of agroforestry management as well as wider environmental benefits for climate change mitigation and adaptation and biodiversity. Currently, several research projects associated with the farm, including the UKRI-funded ‘FARM TREE’ project in collaboration with the University of Aberdeen, which is part of the Future of UK Treescapes Programme. The ‘FARMTREE’ project concerns balancing farm and landscape-scale demands for integrating trees on agricultural land and is developing practical tools for farmers to enhance the expansion of trees on agricultural land.
    Building on lessons learned from these original research plots, as well as from agroforestry studies elsewhere, Hutton researchers planted a new design of silvopastoral agroforestry in early 2024. This integrates oak, a range of other amenity trees and grazing pasture, aiming to maximise the multiple potential benefits and minimise any disbenefits from such a system.
    Professor Alison Hester, who heads up the Climate-Positive Farming Initiative at Glensaugh, said, “We’re delighted to host day two of this year’s farm Woodland Forum Annual Meeting at Glensaugh. Glensaugh has been a core site for agroforestry research since the 1980s and it is wonderful to see the bourgeoning enthusiasm for greater integration of trees into farming systems with all the multiple benefits that this can bring.”

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: University awarded prestigious AHRC Doctoral Focal Awards to power creative economy in rural areas The University of Aberdeen is part of a consortium which has been awarded a major AHRC Doctoral Focal Award in the Creative Economy.

    Source: University of Aberdeen

    The University of Aberdeen is part of a consortium which has been awarded a major AHRC Doctoral Focal Award in the Creative Economy.
    The Celtic Crescent Creative Economy Doctoral Focal Award will spearhead innovative research into the role of bilingual and rural communities in the creative economy, with a focus on regions often overlooked in national creative strategies.
    This award will fund 20 PhDs and brings together a consortium of universities committed to bilingualism, led by Bangor University and including Aberystwyth University, Falmouth University, Glasgow School of Art, the Royal Welsh College of Music and Drama, The University of Aberdeen and the University of South Wales.
    The consortium is supported by 27 industry and sectoral partners, ranging from national public bodies, theatre groups, media producers and internationally recognised craft producers like Harris Tweed. The funding will support doctoral training focused on building research capacity in strategic areas.
    Professor Nick Forsyth, the University of Aberdeen’s Vice-Principal for Research said: “The University of Aberdeen is proud to work with partners on this important initiative which supports young scholars and will create inclusive, impactful research that will strengthen regional economies and enhance cultural life across the UK. This award underscores the University’s international reputation for research excellence in the arts and humanities, following our recent successful AHRC Doctoral Landscape Award, and demonstrates our commitment to supporting and preparing the next generation of scholars to ensure the vitality of these subjects.”
    This initiative will strengthen collaboration between academia, industry, and communities to deliver broader societal benefits with a key focus on addressing underrepresentation and closing skills gaps in the sector.
    Professor Michelle Macleod, Head of the School of Language, Literature, Music and Visual Culture and Co-Investigator and Impact and Engagement Lead on the Celtic Crescent Management Board, said: “This is a wonderful opportunity to develop a cohort of new researchers in the area of the creative economy with expertise in place-based, multidisciplinary research. Our focus is on the vital role that rural, coastal and multilingual communities play in the UK’s creative industry, recognised by the government as a driver for growth, and, crucially, creating a talent pipeline that will be a driving force for industrial innovation.”
    PhD students will be provided with hands-on research opportunities in collaboration with industry partners and community organisations. The focus will be on developing future-facing skills and opening up career pathways both within and beyond academia, particularly in underrepresented areas and sectors.
    Recruitment for the Celtic Crescent PhDs will open next year, with students beginning in autumn 2026.
    Thugadh Duaisean Dotaireachd Fòcasach cliùiteach AHRC do Oilthigh Obar Dheathain gus eaconamaidh chruthachail ann an sgìrean dùthchail a neartachadh
    Tha Oilthigh Obar Dheathain na phàirt de cho-bhanntachd a fhuair Duais Dotaireachd Fòcasach mhòr bhon AHRC ann an Eaconamaidh Chruthachail.
    Bidh Duais Dotaireachd Fòcasach Eaconamaidh Chruthachail Celtic Crescent a’ stiùireadh rannsachadh ùr-ghnàthach air àite choimhearsnachdan dà-chànanach is dùthchail san eaconamaidh chruthachail, le fòcas air roinnean air an dèanar dearmad gu tric ann an ro-innleachdan cruthachail nàiseanta. Bheir an duais seo maoineachadh do 20 PhD agus tha i a’ toirt còmhla com-pàirteachas de dh’oilthighean a tha dealasach a thaobh dà-chànanachais, air a stiùireadh le Oilthigh Bangor agus a’ gabhail a-steach Oilthigh Aberystwyth, Oilthigh Falmouth, Sgoil Ealain Ghlaschu, Colaiste Rìoghail Ciùil is Dràma na Cuimrigh, Oilthigh Obar Dheathain agus Oilthigh Chuimrigh a Deas. Tha 27 com-pàirtichean gnìomhachais is roinneil a’ toirt taic don cho-bhanntachd, a’ gabhail a-steach buidhnean poblach nàiseanta, buidhnean theatar, riochdairean meadhanan agus riochdairean ciùird a tha aithnichte gu h-eadar-nàiseanta leithid Clò na Hearadh.
    Cuiridh am maoineachadh taic ri trèanadh dotaireil a tha ag amas air comasan rannsachaidh a thogail ann an raointean ro-innleachdail.
    Thuirt an t-Àrd Ollamh Nick Forsyth, Iar-Phrionnsabal airson Rannsachadh aig Oilthigh Obar Dheathain:
    “Tha Oilthigh Obar Dheathain moiteil a bhith ag obair le com-pàirtichean air a’ phròiseact chudromach seo agus tha sinn a’ coimhead air adhart ri bhith ag obair air rannsachadh buadhmhor agus in-ghabhalach a bhios a’ cumail taic ri sgoilearan ùra agus aig a’ cheart àm a bhios a’ neartachadh eaconamaidhean roinneil agus a’ leasachadh beatha chultarail na RA. Tha an duais seo a’ daingneachadh cliù eadar-nàiseanta an Oilthigh airson sàr-mhathas rannsachaidh anns na h-ealain agus na daonnachdan, às dèidh dhuinn Doctoral Landscape AHRC fhaighinn o chionn ghoirid, agus tha e a’ sealltainn ar dealas a thaobh taic a thoirt don ath ghinealach de sgoilearan a neartaicheas na cuspairean seo.”
    Neartaichidh an iomairt seo co-obrachadh eadar an saoghal acadaimigeach, gnìomhachas agus coimhearsnachdan gus buannachdan sòisealta nas fharsainge a lìbhrigeadh le prìomh fhòcas air dèiligeadh ri fo-riochdachadh agus beàrnan sgilean san roinn a dhùnadh.
    Thuirt an t-Àrd Ollamh Michelle NicLeòid, Ceannard Sgoil Cànain, Litreachais, Ciùil agus Cultar Lèirsinnich agus Co-Rannsaiche agus Stiùiriche Buaidh is Conaltraidh air Bòrd Riaghlaidh Celtic Crescent:
    “’S e cothrom air leth a tha seo buidheann de luchd-rannsachaidh ùra a leasachadh ann an raon na h-eaconamaidh cruthachail le eòlas ann an rannsachadh ioma-chuspaireil suidhichte air àite. Tha ar fòcas air a’ phàirt chudromaich a th’ aig coimhearsnachdan dùthchail, ioma-chànanach air a’ chosta ann an gnìomhachas cruthachail na RA, aithnichte leis an riaghaltas mar chulaidh-bhrosnachaidh airson fàs eaconomach, agus ann a bhith a’ cruthachadh tàlant ùr a bhios na fheachd leasachaidh airson ùr-ghnàthachadh gnìomhachais.”
    Gheibh oileanaich PhD cothroman rannsachaidh practaigich ann an co-obrachadh le com-pàirtichean gnìomhachais agus buidhnean coimhearsnachd. Bidh am fòcas air sgilean a tha freagarrach don àm ri teachd a leasachadh agus slighean dreuchdail fhosgladh an dà chuid taobh a-staigh agus taobh a-muigh saoghal nan oilthighean, gu sònraichte ann an raointean air an riochdachadh gu leòr.
    Tòiseachaidh trusadh airson sgoilearachdan PhD Celtic Crescent an ath-bhliadhna, le oileanaich a’ tòiseachadh san fhoghar 2026.

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Upgrades underway at Coronation Park Splashpad08 July 2025 A series of improvements are being made to enhance the experience for visitors at the Splashpad in Coronation Park this summer. New shade structures and changing huts are being installed to make visits… Read more

    Source: Channel Islands – Jersey

    08 July 2025

    A series of improvements are being made to enhance the experience for visitors at the Splashpad in Coronation Park this summer. 

    New shade structures and changing huts are being installed to make visits more comfortable for all. 

    The enhancements aim to support family-friendly facilities and provide better on-site amenities. 

    To improve safety and help deter vandalism, CCTV will also be installed across the park. 

    • CCTV installation begins on Monday 7 July and will take approximately one week to complete 
    • Shade and changing facilities installation also starts on Monday 7 July, with work expected to last two weeks. 

    While part of the rear of the park will be closed off during this period, the Splashpad will remain open throughout the works. 

    These improvements reflect the ongoing commitment to maintain Coronation Park as a welcoming and safe space for all visitors.​

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Public Health and Safety in Rented Dwellings – first year of licensing scheme08 July 2025 The Government of Jersey has published the first Annual Report on Public Health and Safety in Rented Dwellings, offering a review of the licensing scheme’s first year in operation. The report evaluates… Read more

    Source: Channel Islands – Jersey

    08 July 2025

    The Government of Jersey has published the first Annual Report on Public Health and Safety in Rented Dwellings, offering a review of the licensing scheme’s first year in operation. 

    The report evaluates the scheme’s introduction, implementation, and impact. It highlights the Government’s work to improving housing standards and protecting Islanders living in rented accommodation. 

    Key findings from the first year include: 

    • Over 18,000 properties licensed under the new framework. 
    • 203 inspections carried out, with 60% of properties found to have no recorded hazards at the time of inspection. 
    • In the remaining 40%, between 1 and 9 hazards were identified per property, offering a valuable evidence base to guide future enforcement and support. 
    • Data shows strong consistency between proactive inspections and those carried out in response to complaints, reinforcing confidence in the inspection process and risk-based approach. 

    The report also details common hazards, licensing conditions, enforcement measures, and provides a financial summary of the scheme’s operation.

    Minister for the Environment, Deputy Steve Luce, welcomed the report’s findings: “This first year of licensing has set a strong foundation for the future. I’m pleased to see over 18,000 rented properties now licensed and a clear demonstration of landlord responsibility across the Island. 

    “Most rental homes are being well maintained, which speaks to the shared commitment we all have to improving housing quality. This scheme is helping us raise standards while targeting interventions where they’re needed most.” 

    The licensing scheme under the Public Health and Safety (Rented Dwellings) (Jersey) Law 2018 plays a vital role in safeguarding the health, safety, and wellbeing of Islanders living in rented homes. 

    The report shows its importance as a long-term policy tool and outlines key priorities for the year ahead.​

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Life-changing work of York foster carers recognised

    Source: City of York

    Published Monday, 7 July 2025

    The life-changing work of some of York’s longest serving foster carers has been recognised at a special awards ceremony this month.

    The life-changing work of some of York’s longest serving foster carers has been recognised at a special awards ceremony this month.

    13 foster carer households were awarded certificates for completing 20, 30 and 40 years of fostering, adding up to a combined total of 320 years of fostering service, providing safe, loving homes to local children and young people who can’t live with their birth families.

    Longest serving of the foster carers recognised at the event were Sue and Martyn Hill, who have fostered children and young people for 40 years.

    Sue Hill, foster carer, said:

    Fostering has brought us so much pleasure over the years, as well as some challenging moments but it has certainly enriched our lives and hopefully that of the children we have cared for. We can’t think of anything else that we would rather have done in life. Hopefully we will carry on for a good bit longer!”

    Cllr Bob Webb, City of York Council’s Executive Member for Children, Young People and Education, said: “Our foster carers are a hugely valued part of a wider team supporting children and young people in our care. I’m delighted that we’ve been able to recognise the incredible impact our carers have had and would urge anyone who’s considering fostering to get in touch. There are few other roles which give people the chance to make such a positive contribution to young people’s lives. And with a fostering package that is now amongst the best available in the region, there’s never been a better time to foster for City of York Council.”

    Martin Kelly OBE, Corporate Director of Children’s Services and Education at City of York Council, presented the awards. He said: “It is a huge honour for me to present these long service awards to some of our amazing foster carers. The work that they do really is life changing and their commitment and dedication to supporting local children and young people is inspirational.”

    Find out more about fostering for York at Fostering York website.

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: Scene is set for outdoor theatre at Abbey Pumping Station

    Source: City of Leicester

    THE GROUNDS of Leicester’s Abbey Pumping Station will become the setting for an open-air production of a classic 18th century comedy of manners next week.

    Sheridan’s ‘The Rivals’ will be performed by the Rain or Shine Theatre Company – whatever the weather – at 7pm on Friday 18 July.

    The play has delighted audiences for more than 250 years, featuring a cast of characters embroiled in a whirlwind plot of comic confusion, daring duels and romantic entanglement.

    Set in the spa town of Bath, this brand new adaptation combines Sheridan’s masterpiece with Rain or Shine’s fast and furious comic flair.

    Tickets for the family-friendly farce are now on sale and priced at £17.34 for adults and £8.67 for those aged 15 and under (price includes booking fee).

    Seating is not provided, so ticket holders are invited to bring their own picnic blankets or low-backed chairs for the performance.

    For full information and to book tickets, please go to leicestermuseums.org

    MIL OSI United Kingdom

  • MIL-OSI United Kingdom: ‘Ultra-wealthy and large corporations must pay their fair share’ – Plaid Cymru

    Source: Party of Wales

    Liz Saville Roberts urges UK Government to implement fairer taxation system instead of policies that disproportionately hit Wales 

    Plaid Cymru’s Westminster Leader, Liz Saville Roberts MP, has today (Monday 7 July) urged the UK Government to commit to creating a fairer taxation system whereby the ultra-wealthy and large corporations pay their fair share. 

    Ms Saville Roberts argued that implementing a wealth tax on assets over £10 million would be a fairer policy. 

    A 2% tax on assets over £10 million could raise up to £24 billion every year. 

    She also argued that the Government could clamp down on tax evasion as well as end government subsidies for oil and gas giants. 

    In addition to raising Employer National Insurance Contributions, the Chancellor Rachel Reeves MP, has proposed a number of cuts in her first year in office including the Winter Fuel Payment and disability benefits.  

    Liz Saville Roberts highlighted how these policies “disproportionately hit Welsh communities” but suggested alternatives in order to raise the necessary funds for the Treasury. 

     

    Speaking in the House of Commons, Liz Saville Roberts MP said: 

    “Plans to plunder disability benefits and the decision to hike National insurance are examples of policies which disproportionately hit Welsh communities. 

    “Instead, we need fair policies like a wealth tax on assets over £10 million, ending government subsidies for the oil and gas giants and clamping down on tax evasion. 

    “So when will the Government’s fiscal rules enshrine fairness where the ultra-wealthy and large corporations pay their fair share?” 

     

    In his response, the Treasury’s Chief Secretary, Darren Jones MP said: 

    “I think the Honourable Lady has missed the fact that this Government has changed the non-dom tax status – these are the wealthiest people in our country for many years – VAT on private schools and it’s more expensive now to fly a private jet than under the former Prime Minister under the Conservative Party opposite and as a consequence of the decisions the Chancellor took at the Budget last year, we’ve given the largest real terms increase in spending to Wales since devolution began and as a consequence of our reforms to the Bill coming on Wednesday we’ve increased the base rate of Universal Credit for the first time in many, many years.” 

    MIL OSI United Kingdom